Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
This share is going down like Tesla...
yea, i'm sure he must be clueless that is why he's got so much extra money to invest....
Haha, everything is possible ;'))
What is missing in your post is whether you directed it to a long or short term investors. In case of the first ones, you are asking this question a few years too early as the current price is totally irrelevant to them ;'))
For once I'm going to defend LGO, his recent posts are actually what I would gladly see as a decent standard for any critical approach to the info being posted/discussed here, there is finally some valid thinking/logic behind it.
I don't think LGO needs any evidence to come up with his claims, this is how it works and this is the whole fun for him, type quickly the same text until you master it, over and over again, like a proper bot ;'))
Quick point, if someone lists CBX as a competitor that shares the same market with Kanabo, Love hemp, chill etc. it shows basic lack in understanding of the CBX lead product (skin care) which has nothing or at least very little to do with the listed competitors offerings and their market.
It doesn't mean that CBX product will do great straightaway, I'm simply pointing out that before someone invest in a company it is worth to learn about it first.
And a bit of advice for those that want to make certain money, stay away from the stock market, get a second job, work overtime etc.
I would say even 15days or so, I remember the same pattern back then.
It is not only amazon (however, anything under 2700$ is undervalued, even more at 2240$) , Peabody energy 30% down, AMR 15% , Tesla 20%, and so on..
interest rates going up, there has been some sell out across the whole market, even amazon is down by 30% over the last 2-3 weeks, same others. good times for investors with money.
I think that reading the definition of a 'start-up' company should help you understand that. If you don't like my extract below feel free to use 'google', which sometimes might be worth doing in the first place to save this type of questions:
''Startups typically begin by a founder (solo-founder) or co-founders who have a way to solve a problem. The founder of a startup will begin market validation by problem interview, solution interview, and building a minimum viable product (MVP), i.e. a prototype, to develop and validate their business models. The startup process can take a long period of time (by some estimates, three years or longer), and hence sustaining effort is required. Over the long term, sustaining effort is especially challenging because of the high failure rates and uncertain outcomes. Having a business plan in place outlines what to do and how to plan and achieve an idea in the future.
Typically, these plans outline the first 3 to 5 years of your business strategy.''
Two things are certain. We are living in very exiting times. The second, and most important, don't think that any real investing professionals would visit this forum to contribute on the topic, so I would take with a big grain of salt whatever is being posted here, regardless which side of the fence.
It seems to be across the board, Amazon 7.5% down, same Tesla, Peabody Energy.... and these are solid, mature companies.
You Windows are trying so hard to 'educate' others with your black & white views but it seems that you failed yourself at the matter, assuming you had invested, then panicked (whatever you call it) and sold at a loss (hence the bitterness). I don't expect to make a fortune next month, in fact, i recognised from the start it would takes years (even dough you can make a decent profit on daily ups/downs as i did on AMC, for example), especially for IPO business that is still developing and practically on the market barely 4 months since they started introducing their products (so it is pointless suggesting i should be looking back as far as one year when the SP is concerned). They got very good quality products (skin care department) that I'm willing to keep buying, seeing clearly the difference (comparing to what I used to buy), so that is my main answer to your 'why'.
As for the WLLW, I would expect their SP to recover back to 2$ once the market (especially US one) has got all the regulations in place (= operational clarity).
Don't just read the SP, read and try to understand the context (i.e. regulations), but regardless, their financial situations looks very healthy, so absolutely nothing to worry about here:
''Willow Biosciences has said it is in a strong financial position with $30.1 million cash on the balance sheet at the end of the year to December 31, 2021, as the company continues to progress its cannabinoid program to a state of readiness for when market opportunities open.
"2021 was both an exciting and challenging year for Willow," said Trevor Peters, Willow's president and chief executive officer in a statement. "The progress that we continue to make building out our core platform technology is setting the company up to be a leader in the bio revolution that is unfolding around us.”
Peters noted that the market for cannabinoids has seen headwinds due to the lack of clarity around the regulatory future of cannabis, predominantly in the US, which is causing larger consumer companies to remain on the sidelines until more certainty is given by lawmakers.
“Willow management believes this to only be temporary, given the bipartisan support, for instance, seen in the US toward decriminalisation and ultimate legalisation,” he said. ''
If I'm not mistaken you (Muma) made a profit trading CBX shares and also remember very clearly you saying the SP will 100% go up 10+ within weeks (to potentially encourage people to buy quickly more so you can then sell), not sure which category you are sitting in currently (unless you are sort of double agent). In short, wouldn't trust a word you say.
Not sure what is Windows exact motive, but I guess, it is most likely also driven by money ;'))
That is the mentality of SOME people that sold at a loss, they want others to experience the same so it hurts if that doesn't happen.
'' A managing partner at an EU law firm says the FSA should implement complete removal of all CBD products to ensure the novel foods regulation is implemented correctly. In his view the list is discriminatory and nonsensical as you can have a company that may have invested more than £300k on a novel foods dossier but be on the market after FSA's 13 February deadline not being allowed to sell.
On the other hand, you could have a firm with no data only the promise of generating some but because they were on the market (illegally as with all other CBD products) before that date but permitted to remain on the market. If industry wants to challange the current public list and such unfairness, they are on borrowed time with only 3 months from the publication of the list to bring a judicial review.''
It is very simple:
1) The category hasn't been regulated properly in the first place, that is why it requires some further debate to clarify things (don't think that CBX wants to be in the same bag with others), therefore, it can only help with the sales, otherwise, what would be a point in marketing in general ?
The legal case can be used as a marketing tool to sell positive story about the product.
2) The lack of any vibes is the most negative thing in my opinion.
3) And very well, CBX should easily be in that position to answer the questions and tick all the safety boxes once defined (this is the whole point, if you read the article you will have seen that FSA failed to convey in a clear way what the requirements really are that shall now be met).
It may not be that obvious for many but it is a very promising situation for CBX.
As it says in the article, many affected brands do consider now taking legal actions against FSA.
To get nationwide recognition/attention it would cost CBX a fortune, but now, FSA is offering it to them for FREE.
More so, joining others in a legal suit would most likely create CBX a leader of the pack (the phrase ''CBX - David Beckam's backed company'' is simply too attractive for the media) and also to quicker establish themselves on the market and distance from the others.
Besides, the whole market needs some stir and this would be a good opportunity.
Obviously, FSA could simply add CBX back on the list, but that would be less of a win comparing to the full legal action, especially, as many already mentioned, CBX main target is the skin care market, and everything else is sort of a side product, a bit like gin for whisky making companies, at least in my view.
Yeah, CBX has responded very quickly:
https://www.marketwatch.com/story/cellular-goods-seeks-further-clarification-from-uk-food-regulator-on-banned-products-271649838242?mod=mw_quote_news
and with very important note:
"The company's skincare range, which accounts for the bulk of its overall sales, remains unaffected," it added.